Leading expert in thoracic oncology and mesothelioma treatment, Dr. Dean Fennell, MD, explains his extensive background in cancer research. He is a Professor of Thoracic Medical Oncology at the University of Leicester. Dr. Fennell has published over 200 peer-reviewed articles. He holds leadership roles in major international cancer organizations.
Mehr von DiagnosticDetectives.Com
Expert Insights on Mesothelioma Treatment and Research
Jump To Section
- Mesothelioma Treatment Expert
- Academic and Clinical Appointments
- Education and Training
- Professional Leadership Roles
- Research Contributions
- Full Transcript
Mesothelioma Treatment Expert
Dr. Dean Fennell, MD, is a globally recognized authority in the treatment of mesothelioma. His expertise spans clinical care and advanced research in thoracic oncology. Dr. Fennell has dedicated his career to improving outcomes for patients with this aggressive cancer.
Academic and Clinical Appointments
Dr. Dean Fennell, MD, holds the prestigious position of Professor of Thoracic Medical Oncology at the University of Leicester. This role involves both treating patients and leading innovative research programs. His work at this institution places him at the forefront of mesothelioma care in Great Britain.
Education and Training
Dr. Fennell earned his MD and PhD in Oncology from the renowned University College London. He further honed his skills at several of London's most esteemed hospitals. His clinical training included positions at Guy’s and St Thomas’ Hospitals and St Bartholomew’s Hospital.
Professional Leadership Roles
Dr. Dean Fennell, MD, is a Fellow of the Royal College of Physicians in London. He has held significant leadership positions in major international cancer organizations. These include the European Organisation for Research and Treatment of Cancer (EORTC), the International Mesothelioma Interest Group, and the International Association for the Study of Lung Cancer.
Research Contributions
Professor Fennell has made substantial contributions to medical literature with over 200 peer-reviewed publications. His research focuses primarily on lung cancer and mesothelioma treatment strategies. These publications have advanced the global understanding of thoracic oncology and influenced clinical practice guidelines.
Full Transcript
Dr. Anton Titov, MD: Hello from New York! We are with Dr. Dean Fennell, an expert in thoracic oncology. We will discuss mesothelioma today.
Dr. Dean Fennell is a professor of thoracic medical oncology at the University of Leicester, Great Britain. Professor Fennell is one of the world’s leaders in mesothelioma research and treatment.
Dr. Fennell obtained his MD and PhD in oncology from University College London. He continued his clinical and research work at several renowned London hospitals, including Guy’s and St Thomas’ Hospitals and St Bartholomew’s Hospital in London.
Dr. Fennell is a fellow of the Royal College of Physicians (London) and has had leadership positions at the European Organisation for Research and Treatment of Cancer (EORTC), International Mesothelioma Interest Group, and Association for the Study of Lung Cancer.
Professor Fennell published over 200 articles in peer-reviewed medical journals on the research and treatment of lung cancer and mesothelioma.
Professor Fennell, hello and welcome!
Dr. Dean Fennell, MD: Thank you very much indeed for the invitation to speak with you today.